Critical Outcome Technologies Grants Stock Options

(firmenpresse) - LONDON, ONTARIO -- (Marketwired) -- 10/15/13 -- Critical Outcome Technologies Inc. (COTI) (TSX VENTURE: COT) announced today that pursuant to an existing consulting agreement, the Board of Directors granted 200,000 stock options (Options) to Dr. Brent Norton who is also a director of the Company, on October 15, 2013.

The Options are exercisable at a price of $0.24 and have a five year expiry term. The Options vest as follows: 50,000 immediately and 50,000 on each of December 1, 2013, March 1, 2014 and June 1, 2014.

About Critical Outcome Technologies Inc. (COTI)

COTI is a leading-edge technology company specializing in accelerating the discovery and development of small molecules - dramatically reducing the time and cost to bring new drugs to market. COTI'S proprietary artificial intelligence system, CHEMSAS®, utilizes a series of predictive computer models to identify compounds with a high probability of being successfully developed from disease specific drug discovery through chemical optimization and preclinical testing. These compounds are targeted for a variety of diseases, particularly those for which current treatments are either lacking or ineffective.

Follow (at)CriticalOutcome on Twitter at

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.



Contacts:
Critical Outcome Technologies Inc.
Dr. Wayne Danter
President & CEO
519-858-5157



Heisler Communications
Trevor Heisler
Investor Relations
416-500-8061

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 15.10.2013 - 20:30 Uhr
Sprache: Deutsch
News-ID 306062
Anzahl Zeichen: 0

contact information:
Town:

LONDON, ONTARIO

Kategorie:

Biotech

Diese Pressemitteilung wurde bisher 233 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Critical Outcome Technologies Grants Stock Options"
steht unter der journalistisch-redaktionellen Verantwortung von

Critical Outcome Technologies Inc. (COTI) (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Critical Outcome Technologies Closes Financing ...

LONDON, ONTARIO -- (Marketwired) -- 12/22/14 -- Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Corporation") the biopharmaceutical company that uses machine learning to rapidly develop targe ...

Critical Outcome Technologies Inc. Extends Warrants Set to Expire December 20, ...

LONDON, ONTARIO -- (Marketwired) -- 12/18/14 -- Critical Outcome Technologies Inc. ("COTI" or the "Company") (TSX VENTURE: COT)(OTCQB: COTQF), the biopharmaceutical company that uses machine learning to rapidly develop targeted ...

Critical Outcome Technologies Reports Fiscal 2015 Second Quarter Results ...

LONDON, ONTARIO -- (Marketwired) -- 12/17/14 -- Critical Outcome Technologies Inc. (TSX VENTURE: COT)(OTCQB: COTQF) ("COTI" or the "Company") the biopharmaceutical company that uses machine learning to rapidly develop targeted t ...

Alle Meldungen von Critical Outcome Technologies Inc. (COTI)